Los Angeles, CA -- (SBWIRE) -- 04/11/2019 -- Infertility Drugs are drugs which enhance reproductive fertility. For women, Infertility Drugs is used to stimulate follicle development of the ovary. Agents that enhance ovarian activity can be classified as either Gonadotropin releasing hormone, Estrogen antagonists or Gonadotropins.
The five major types of ovulation drug therapy are Clomid (Serophene, clomiphene citrate), Femara or letrozole and other aromatase inhibitors, injectable gonadotropins and injectable FSH hormone products, the GnRH pump and Bromocriptine.
The global Infertility Drugs market was 3860 million US$ in 2018 and is expected to 6750 million US$ by the end of 2025, growing at a CAGR of 7.2% between 2019 and 2025.
This report studies the Infertility Drugs market size (value and volume) by players, regions, product types and end industries, history data 2014-2018 and forecast data 2019-2025; This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.
Get PDF template of this report: https://www.qyresearch.com/sample-form/form/1108761/global-infertility-drugs-market
Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Infertility Drugs in these regions, from 2014 to 2025, covering
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia and Turkey etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil etc.)
Middle East and Africa (Egypt and GCC Countries)
The various contributors involved in the value chain of the product include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in this market include
Bayer Zydus Pharma
By the product type, the market is primarily split into
By the end users/application, this report covers the following segments
We can also provide the customized separate regional or country-level reports, for the following regions:
Rest of Asia-Pacific
Rest of Europe
Central & South America
Rest of Central & South America
Middle East & Africa
Get Full Report Now at USD 3,550 @ https://www.qyresearch.com/settlement/pre/11cf7e39bc20f0f8404d0c12e0b12b1b,0,1,Global%20Infertility%20Drugs%20Market%20Report,%20History%20and%20Forecast%202014-2025,%20Breakdown%20Data%20by%20Manufacturers,%20Key%20Regions,%20Types%20and%20Application
QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from the huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in the consulting industry.